Trials / Sponsors / Cell Medica Ltd
Cell Medica Ltd
Industry · 8 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse, Post-transplant Lymphoproliferative Disorder | Phase 2 | 2016-11-01 |
| Terminated | Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogenei Infectious Complications Following HSCT | — | 2016-05-11 |
| Completed | A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients Myelodysplastic Syndromes (MDS), Acute Myeloid Leukaemia (AML) | Phase 1 / Phase 2 | 2015-09-01 |
| Terminated | Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma Lymphoma, Extranodal NK-T-Cell, EBV | Phase 2 | 2014-09-01 |
| Completed | Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT ADV Infection Post Allo-HSCT | Phase 1 / Phase 2 | 2012-12-01 |
| Completed | WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia | Phase 1 / Phase 2 | 2012-04-01 |
| Completed | Alternate Donor Study of Pre-Emptive Cellular Therapy Cytomegalovirus Infection | Phase 2 | 2010-10-01 |
| Completed | Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study Cytomegalovirus Infection | Phase 3 | 2008-07-01 |